Richard Jacinto Ii bought $1.4M of DiaMedica Therapeutics (DMAC)

Executed Jul 23 2025, disclosed Jul 25 2025, 2 days later.

Value, as filed

$1.4M

400,000 sh × $3.50

Executed

Jul 23 2025

the trade date, as filed

Disclosed

Jul 25 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+24.4%

+30.2% from execution

Over the 21 trading sessions from the disclosed entry session (Jul 25 2025), the stock returned +24.4% (delay-adjusted); from the execution session (Jul 23 2025), +30.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

RI Richard Jacinto Ii 10% owner profile →

Richard Jacinto Ii (10% owner) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in DMAC. Across 1 priced purchase filing, the average 21-session return was +30.2% from execution and +24.4% from disclosure (delay-adjusted; derived). The largest single filing was $1.4M of DMAC (400,000 sh × $3.50, as filed), executed Jul 23 2025.

The name

DMAC DMAC DMAC · 5 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→